Cargando…
Dissolution enhancement of albendazole through nanocrystal formulation
Albendazole, a BCS class II drug, has poor dissolution characteristic. In order to enhance dissolution nanocrystals were prepared by antisolvent precipitation process using PVP K-30(0.05%,0.1%,0.2%,0.4%) as stabilizer. The process was optimized in terms of concentration of stabilizer(PVP K 30) in or...
Autores principales: | Koradia, D. Krishna, Parikh, H. Rajesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467808/ https://www.ncbi.nlm.nih.gov/pubmed/23066210 http://dx.doi.org/10.4103/0975-7406.94141 |
Ejemplares similares
-
Formulation development of chewable albendazole tablets with improved dissolution rate
por: Kimaro, Emmanuel, et al.
Publicado: (2019) -
Formulation Development of Albendazole-Loaded Self-Microemulsifying Chewable Tablets to Enhance Dissolution and Bioavailability
por: Sawatdee, Somchai, et al.
Publicado: (2019) -
Nanocrystal Suspensions for Enhancing the Oral Absorption of Albendazole
por: Liang, Zhiwei, et al.
Publicado: (2022) -
Enhancement of dissolution of Telmisartan through use of solid dispersion technique - surface solid dispersion
por: Patel, Bhumika, et al.
Publicado: (2012) -
Driving Organic Nanocrystals Dissolution Through Electrochemistry
por: Bussetti, Gianlorenzo, et al.
Publicado: (2021)